Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer ; day:11 ; month:11 ; year:2017 ; pages:1-11
Breast cancer research and treatment ; (11.11.2017), 1-11
- Keyword
-
Krebs
Onkologie
- Creator
-
Bostner, Josefine
- Contributor
-
Alayev, Anya
Berman, Adi Y.
Fornander, Tommy
Nordenskjöld, Bo
Holz, Marina K.
Stål, Olle
SpringerLink (Online service)
- DOI
-
10.1007/s10549-017-4508-x
- URN
-
urn:nbn:de:1111-201801107241
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bostner, Josefine
- Alayev, Anya
- Berman, Adi Y.
- Fornander, Tommy
- Nordenskjöld, Bo
- Holz, Marina K.
- Stål, Olle
- SpringerLink (Online service)
Other Objects (12)
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo
Small molecule inhibitor targeting the Hsp70-Bim protein–protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer
Molecular markers associated with the outcome of tamoxifen treatment in estrogen receptor-positive breast cancer patients: scoping review and in silico analysis
PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
Raptor - Rusticus
The impact of CBP expression in estrogen receptor-positive breast cancer
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo
Small molecule inhibitor targeting the Hsp70-Bim protein–protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer
Molecular markers associated with the outcome of tamoxifen treatment in estrogen receptor-positive breast cancer patients: scoping review and in silico analysis
PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
Raptor - Rusticus
The impact of CBP expression in estrogen receptor-positive breast cancer
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo
Small molecule inhibitor targeting the Hsp70-Bim protein–protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer
Molecular markers associated with the outcome of tamoxifen treatment in estrogen receptor-positive breast cancer patients: scoping review and in silico analysis
PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
Raptor - Rusticus